Human and Agriculture Gene Editing:
Regulations and Index
Click on a country (eg. Brazil, US) or region (eg. European Union) below to find which human / health products and processes are approved or in development and their regulatory status.
European Union
Brazil
New Zealand
United States
Australia
Canada
China
United Kingdom
Israel
Argentina
Japan
Mexico
Russia
Chile
Uruguay
Paraguay
India
Africa
Ukraine
Southeast Asia
Central America
Colombia
Norway
Ecuador
Human / Health Gene Editing Index
Compare Regulatory Restrictions Country-to-Country
Gene editing regulations worldwide are evolving. The Gene Editing Index ratings below represent the current status of gene editing regulations and will be updated as new regulations are passed.
Colors and ratings guide
Regulation Status | Rating |
---|---|
Determined: No Unique Regulations* | 10 |
Lightly Regulated | 8 |
Proposed: No Unique Regulations† | 6 |
Ongoing Research, Regulations In Development | 5 |
Highly Regulated | 4 |
Mostly Prohibited | 2 |
Limited Research, No Clear Regulations | 1 |
Prohibited | 0 |
†Proposed: No Unique Regulations: Decrees under consideration for gene and stem cell therapies that would not require unique regulations beyond current restrictions on pharmaceuticals.
Rating by Country / Region
Click each column header and arrow to sort the countries / regions
Swipe right/left if all columns aren't visible
Country / Region | Therapeutic | Germline | Human Rating |
---|---|---|---|
Japan | 8 | 8 | 8 |
Brazil | 4 | 0 | 2 |
Canada | 4 | 0 | 2 |
Russia | 10 | 5 | 7.5 |
Argentina | 5 | 1 | 3 |
Israel | 8 | 2 | 5 |
Australia | 4 | 0 | 2 |
China | 8 | 4 | 6 |
US | 4 | 0 | 2 |
Chile | 4 | 1 | 2.5 |
New Zealand | 4 | 0 | 2 |
Ukraine | 10 | 5 | 7.5 |
Central America | 1 | 1 | 1 |
Paraguay | 1 | 1 | 1 |
Uruguay | 1 | 1 | 1 |
India | 4 | 0 | 2 |
UK | 4 | 4 | 4 |
Mexico | 8 | 0 | 4 |
EU | 4 | 0 | 2 |
Click on a country (eg. Brazil, US) or region (eg. European Union) below to find which gene drive products and processes are approved or in development and their regulatory status.
European Union
European Union
Brazil
Brazil
New Zealand
New Zealand
United States
United States
Australia
Australia
Canada
Canada
China
China
United Kingdom
United Kingdom
Israel
Israel
Argentina
Argentina
Japan
Japan
Mexico
Mexico
Russia
Russia
Chile
Chile
Uruguay
Uruguay
Paraguay
Paraguay
India
India
Africa
Africa
Ukraine
Ukraine
Southeast Asia
Southeast Asia
Central America
Central America
Colombia
Colombia
Norway
Norway
Ecuador
Ecuador
Africa
Argentina
Australia
Brazil
Canada
Central America
Chile
China
Colombia
Ecuador
European Union
India
Israel
Japan
Mexico
New Zealand
Norway
Paraguay
Russia
Southeast Asia
Ukraine
United Kingdom
United States
Uruguay
Gene Drive Index
Compare Regulatory Restrictions Country-to-Country
Gene editing regulations worldwide are evolving. The Gene Editing Index ratings below represent the current status of gene editing regulations and will be updated as new regulations are passed.
Colors and ratings guide
Regulation Status | Rating |
---|---|
Determined: No Unique Regulations* | 10 |
Lightly Regulated | 8 |
Proposed: No Unique Regulations† | 6 |
Ongoing Research, Regulations In Development | 5 |
Highly Regulated | 4 |
Mostly Prohibited | 2 |
Limited Research, No Clear Regulations | 1 |
Prohibited | 0 |
†Proposed: No Unique Regulations: Decrees under consideration for gene and stem cell therapies that would not require unique regulations beyond current restrictions on pharmaceuticals.
Rating by Country / Region
Click each column header and arrow to sort the countries / regions
Swipe right/left if all columns aren't visible
Country / Region | Gene Drives | Gene Drive Rating |
---|---|---|
Japan | 1 | 1 |
Brazil | 8 | 8 |
Canada | 8 | 8 |
Russia | 1 | 1 |
Argentina | 1 | 1 |
Israel | 1 | 1 |
Australia | 4 | 4 |
China | 1 | 1 |
US | 4 | 4 |
Chile | 1 | 1 |
New Zealand | 4 | 4 |
Ukraine | 1 | 1 |
Central America | 1 | 1 |
Paraguay | 1 | 1 |
Uruguay | 1 | 1 |
India | 1 | 1 |
UK | 2 | 2 |
Mexico | 1 | 1 |
EU | 2 | 2 |
Click on a country (eg. Brazil, US) or region (eg. European Union) below to find which agriculture products and processes are approved or in development and their regulatory status. The regulations on genetically engineered crops and animals are emerging out of the regulatory landscape developed for transgenic GMOs.
European Union
Switzerland
Switzerland
Brazil
New Zealand
United States
Australia
Canada
China
United Kingdom
Israel
Argentina
Japan
Mexico
Russia
Chile
Uruguay
Paraguay
India
Africa
Ukraine
Southeast Asia
Central America
Colombia
Norway
Ecuador
Cuba
Cuba
Cuba
Agriculture Gene Editing Index
Compare Regulatory Restrictions Country-to-Country
Gene editing regulations worldwide are evolving. The Gene Editing Index ratings below represent the current status of gene editing regulations and will be updated as new regulations are passed.
Colors and ratings guide
Regulation Status | Rating |
---|---|
Determined: No Unique Regulations* | 10 |
Lightly Regulated | 8 |
Proposed: No Unique Regulations† | 6 |
Ongoing Research, Regulations In Development | 5 |
Highly Regulated | 4 |
Mostly Prohibited | 2 |
Limited Research, No Clear Regulations | 1 |
Prohibited | 0 |
†Proposed: No Unique Regulations: Decrees under consideration for gene-edited crops that do not incorporate DNA from another species would no require unique regulations beyond current what is imposed on conventional breeding.
Rating by Country / Region
Click each column header and arrow to sort the countries / regions
Swipe right/left if all columns aren't visible
Country / Region | Food / Crops | Animals | Ag Rating |
---|---|---|---|
Ecuador | 10 | 10 | 10 |
Norway | 6 | 6 | 6 |
Africa | 5 | 5 | 5 |
Japan | 8 | 8 | 8 |
Brazil | 10 | 10 | 10 |
Canada | 8 | 8 | 8 |
Russia | 5 | 5 | 5 |
Argentina | 10 | 10 | 10 |
Israel | 10 | 5 | 7.5 |
Australia | 8 | 8 | 8 |
Switzerland | 5 | 5 | 5 |
China | 5 | 5 | 5 |
US | 10 | 4 | 7 |
Chile | 10 | 1 | 5.5 |
New Zealand | 4 | 4 | 4 |
Ukraine | 1 | 1 | 1 |
Central America | 6 | 6 | 6 |
Paraguay | 10 | 10 | 10 |
Uruguay | 6 | 6 | 6 |
India | 6 | 6 | 6 |
UK | 2 | 2 | 2 |
Mexico | 1 | 1 | 1 |
EU | 2 | 2 | 2 |
Colombia | 10 | 1 | 5.5 |